加强儿科临床试验生态系统以更好地为政策和规划提供依据
2023年11月首届世界卫生组织全球临床试验论坛召开,成立儿科临床试验工作组,汇集儿科各学科代表,识别儿童临床试验生态系统的挑战并提出解决方案。文章指出儿童常被边缘化于临床试验之外,存在优先级与资金不匹配、规避风险、设计不佳、权力失衡和基础设施不足等问题,提出全球、区域和国家机构的行动与责任。
要点
- 儿童常被边缘化于临床试验之外,这是一个公平性问题。
- 挑战包括优先级与资金不匹配、规避风险、设计不佳、权力失衡和基础设施不足。
- 解决方案包括对齐并追踪儿童健康优先级与资金,支持区域联盟 pooled 资源开展更大规模试验。
核心结论
- 儿童常被边缘化于临床试验之外,这是一个公平性问题;许多儿科干预措施的疗效和安全性知识仍存在巨大缺口。
研究设计与样本
- 2023年11月召开首届世界卫生组织全球临床试验论坛,成立儿科临床试验工作组,参与者代表儿科各学科包括传染病、营养、新生儿学、药理学、肿瘤学、神经发育、公共卫生和政策。
主要发现
- 儿童疾病对健康、生计和社会有深远终身影响;投资早期儿童可带来高成本效益的终身健康、生产力和人力资本回报改变。
- 许多儿科干预措施的疗效和安全性知识仍存在巨大缺口,反映政府、研究者、社区和资助者未能建立共同优先级和对齐。
- 挑战包括优先级与资金不匹配、规避风险、设计不佳、权力失衡和基础设施不足。
临床怎么用
- 作者提出全球、区域和国家机构在优先级设定、协调、支持儿科试验联盟、资金和追踪进展方面的行动与责任。
- 作者建议对齐并追踪地方和全球儿童健康优先级与资金,支持区域联盟 pooled 资源开展更大规模、更有影响力的试验。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The first WHO Global Clinical Trials Forum was convened in November, 2023 to develop a shared vision of an effective global clinical trial infrastructure. The Paediatric Clinical Trials Working Group was formed to provide perspectives, identify challenges, and propose solutions to strengthen the paediatric clinical trials ecosystem. Participants represented paediatric disciplines, including infectious diseases, nutrition, neonatology, pharmacology, oncology, neurodevelopment, public health, and policy. Childhood diseases have profound lifelong effects on health, livelihoods, and societies. Investment in early childhood results in highly cost-effective changes to lifelong health, productivity, and human capital returns. Yet, there remain substantial gaps in knowledge on the efficacy and safety of many paediatric interventions, which represents a failure to establish shared priorities and alignment across governments, researchers, communities, and funders. Children are frequently marginalised from clinical trials, which is an issue of equity. Challenges include mismatched priorities and funding, risk adversity, poor design, power imbalances, and inadequate infrastructure. Solutions include aligning on and tracking local and global child health priorities against funding and supporting regional consortia to pool resources for larger, more consequential trials. We propose actions and responsibilities for global, regional, and national institutions for prioritisation, coordination, enabling paediatric trials consortia, funding, and tracking progress.
引用
- Berkley JA, Walson JL, Gray G, et al. Strengthening the paediatric clinical trial ecosystem to better inform policy and programmes. Lancet Glob Health. 2025. PMID: 40155110. doi:10.1016/S2214-109X(24)00511-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。